Genome editing technology refers to the ability of human to "edit" the target gene, such as the deletion and addition of specific DNA fragments.
Highlights
The global Genome Editing and Genome Engineering market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Genome Editing and Genome Engineering is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Genome Editing and Genome Engineering is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Genome Editing and Genome Engineering in Cell Line Engineering is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Genome Editing and Genome Engineering include Thermo Fisher Scientific, Merck, Horizon Discovery, Genscript, Sangamo Biosciences, Integrated DNA Technologies, Lonza, New England Biolabs and Origene Technologies, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Genome Editing and Genome Engineering, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genome Editing and Genome Engineering.
The Genome Editing and Genome Engineering market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Genome Editing and Genome Engineering market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genome Editing and Genome Engineering companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Thermo Fisher Scientific
Merck
Horizon Discovery
Genscript
Sangamo Biosciences
Integrated DNA Technologies
Lonza
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
Crispr Therapeutics
Tecan Life Sciences
Segment by Type
CRISPR
TALEN
ZFN
Segment by Application
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Genome Editing and Genome Engineering companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Genome Editing and Genome Engineering 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 CRISPR
1.2.3 TALEN
1.2.4 ZFN
1.3 麻豆原创 by Application
1.3.1 Global Genome Editing and Genome Engineering 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cell Line Engineering
1.3.3 Animal Genetic Engineering
1.3.4 Plant Genetic Engineering
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genome Editing and Genome Engineering 麻豆原创 Perspective (2018-2029)
2.2 Genome Editing and Genome Engineering Growth Trends by Region
2.2.1 Global Genome Editing and Genome Engineering 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Genome Editing and Genome Engineering Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Genome Editing and Genome Engineering Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Genome Editing and Genome Engineering 麻豆原创 Dynamics
2.3.1 Genome Editing and Genome Engineering Industry Trends
2.3.2 Genome Editing and Genome Engineering 麻豆原创 Drivers
2.3.3 Genome Editing and Genome Engineering 麻豆原创 Challenges
2.3.4 Genome Editing and Genome Engineering 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genome Editing and Genome Engineering Players by Revenue
3.1.1 Global Top Genome Editing and Genome Engineering Players by Revenue (2018-2023)
3.1.2 Global Genome Editing and Genome Engineering Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Genome Editing and Genome Engineering 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genome Editing and Genome Engineering Revenue
3.4 Global Genome Editing and Genome Engineering 麻豆原创 Concentration Ratio
3.4.1 Global Genome Editing and Genome Engineering 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genome Editing and Genome Engineering Revenue in 2022
3.5 Genome Editing and Genome Engineering Key Players Head office and Area Served
3.6 Key Players Genome Editing and Genome Engineering Product Solution and Service
3.7 Date of Enter into Genome Editing and Genome Engineering 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Genome Editing and Genome Engineering Breakdown Data by Type
4.1 Global Genome Editing and Genome Engineering Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Genome Editing and Genome Engineering Forecasted 麻豆原创 Size by Type (2024-2029)
5 Genome Editing and Genome Engineering Breakdown Data by Application
5.1 Global Genome Editing and Genome Engineering Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Genome Editing and Genome Engineering Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Genome Editing and Genome Engineering 麻豆原创 Size (2018-2029)
6.2 North America Genome Editing and Genome Engineering 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Genome Editing and Genome Engineering 麻豆原创 Size by Country (2018-2023)
6.4 North America Genome Editing and Genome Engineering 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genome Editing and Genome Engineering 麻豆原创 Size (2018-2029)
7.2 Europe Genome Editing and Genome Engineering 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Genome Editing and Genome Engineering 麻豆原创 Size by Country (2018-2023)
7.4 Europe Genome Editing and Genome Engineering 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genome Editing and Genome Engineering 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Genome Editing and Genome Engineering 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Genome Editing and Genome Engineering 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Genome Editing and Genome Engineering 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genome Editing and Genome Engineering 麻豆原创 Size (2018-2029)
9.2 Latin America Genome Editing and Genome Engineering 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Genome Editing and Genome Engineering 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Genome Editing and Genome Engineering 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genome Editing and Genome Engineering 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Genome Editing and Genome Engineering 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Genome Editing and Genome Engineering 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Genome Editing and Genome Engineering 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Genome Editing and Genome Engineering Introduction
11.1.4 Thermo Fisher Scientific Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Genome Editing and Genome Engineering Introduction
11.2.4 Merck Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Horizon Discovery
11.3.1 Horizon Discovery Company Detail
11.3.2 Horizon Discovery Business Overview
11.3.3 Horizon Discovery Genome Editing and Genome Engineering Introduction
11.3.4 Horizon Discovery Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.3.5 Horizon Discovery Recent Development
11.4 Genscript
11.4.1 Genscript Company Detail
11.4.2 Genscript Business Overview
11.4.3 Genscript Genome Editing and Genome Engineering Introduction
11.4.4 Genscript Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.4.5 Genscript Recent Development
11.5 Sangamo Biosciences
11.5.1 Sangamo Biosciences Company Detail
11.5.2 Sangamo Biosciences Business Overview
11.5.3 Sangamo Biosciences Genome Editing and Genome Engineering Introduction
11.5.4 Sangamo Biosciences Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.5.5 Sangamo Biosciences Recent Development
11.6 Integrated DNA Technologies
11.6.1 Integrated DNA Technologies Company Detail
11.6.2 Integrated DNA Technologies Business Overview
11.6.3 Integrated DNA Technologies Genome Editing and Genome Engineering Introduction
11.6.4 Integrated DNA Technologies Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.6.5 Integrated DNA Technologies Recent Development
11.7 Lonza
11.7.1 Lonza Company Detail
11.7.2 Lonza Business Overview
11.7.3 Lonza Genome Editing and Genome Engineering Introduction
11.7.4 Lonza Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.7.5 Lonza Recent Development
11.8 New England Biolabs
11.8.1 New England Biolabs Company Detail
11.8.2 New England Biolabs Business Overview
11.8.3 New England Biolabs Genome Editing and Genome Engineering Introduction
11.8.4 New England Biolabs Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.8.5 New England Biolabs Recent Development
11.9 Origene Technologies
11.9.1 Origene Technologies Company Detail
11.9.2 Origene Technologies Business Overview
11.9.3 Origene Technologies Genome Editing and Genome Engineering Introduction
11.9.4 Origene Technologies Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.9.5 Origene Technologies Recent Development
11.10 Transposagen Biopharmaceuticals
11.10.1 Transposagen Biopharmaceuticals Company Detail
11.10.2 Transposagen Biopharmaceuticals Business Overview
11.10.3 Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Introduction
11.10.4 Transposagen Biopharmaceuticals Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.10.5 Transposagen Biopharmaceuticals Recent Development
11.11 Editas Medicine
11.11.1 Editas Medicine Company Detail
11.11.2 Editas Medicine Business Overview
11.11.3 Editas Medicine Genome Editing and Genome Engineering Introduction
11.11.4 Editas Medicine Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.11.5 Editas Medicine Recent Development
11.12 Crispr Therapeutics
11.12.1 Crispr Therapeutics Company Detail
11.12.2 Crispr Therapeutics Business Overview
11.12.3 Crispr Therapeutics Genome Editing and Genome Engineering Introduction
11.12.4 Crispr Therapeutics Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.12.5 Crispr Therapeutics Recent Development
11.13 Tecan Life Sciences
11.13.1 Tecan Life Sciences Company Detail
11.13.2 Tecan Life Sciences Business Overview
11.13.3 Tecan Life Sciences Genome Editing and Genome Engineering Introduction
11.13.4 Tecan Life Sciences Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.13.5 Tecan Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Thermo Fisher Scientific
Merck
Horizon Discovery
Genscript
Sangamo Biosciences
Integrated DNA Technologies
Lonza
New England Biolabs
Origene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
Crispr Therapeutics
Tecan Life Sciences
听
听
*If Applicable.
